Universal Beteiligungs und Servicegesellschaft mbH Trims Stock Holdings in Cardinal Health, Inc. $CAH

Universal Beteiligungs und Servicegesellschaft mbH reduced its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 4.4% in the third quarter, Holdings Channel.com reports. The fund owned 206,819 shares of the company’s stock after selling 9,508 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Cardinal Health were worth $32,462,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of CAH. Norges Bank purchased a new stake in Cardinal Health in the second quarter worth $584,420,000. Acadian Asset Management LLC increased its stake in Cardinal Health by 92.5% in the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock worth $282,063,000 after buying an additional 807,063 shares during the period. Prudential Financial Inc. increased its stake in Cardinal Health by 476.8% in the 2nd quarter. Prudential Financial Inc. now owns 883,348 shares of the company’s stock worth $148,402,000 after buying an additional 730,209 shares during the period. Voya Investment Management LLC boosted its position in Cardinal Health by 298.3% in the 3rd quarter. Voya Investment Management LLC now owns 821,723 shares of the company’s stock valued at $128,978,000 after buying an additional 615,398 shares during the period. Finally, Worldquant Millennium Advisors LLC bought a new position in Cardinal Health in the 2nd quarter worth about $79,963,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH stock opened at $206.67 on Friday. The stock’s 50-day moving average is $205.72 and its 200 day moving average is $175.90. Cardinal Health, Inc. has a 1-year low of $120.72 and a 1-year high of $215.48. The company has a market cap of $49.10 billion, a P/E ratio of 31.17, a PEG ratio of 1.41 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. During the same period in the prior year, the firm posted $1.88 earnings per share. The company’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd were paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date was Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is 30.77%.

Analyst Ratings Changes

Several analysts have recently weighed in on CAH shares. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday. Argus upped their target price on Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. Barclays initiated coverage on Cardinal Health in a research note on Monday, December 8th. They set an “overweight” rating and a $243.00 price target on the stock. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Finally, TD Cowen increased their target price on shares of Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 3rd. Fourteen investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $219.67.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.